Recommendations of the Advisory Committee on Immunization Practices for use of herpes
zoster vaccines - ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & …

Herpes zoster (HZ) affects approximately 1 in 3 persons in their lifetime, and the risk of HZ
increases with increasing age. The most common, debilitating complication of HZ is the …

Importance Herpes zoster, a frequent complication following autologous hematopoietic stem
cell transplantation (HSCT), is associated with significant morbidity. A nonlive adjuvanted …

Abstract Live, attenuated Oka/Merck varicella-zoster virus (VZV) vaccine (zoster vaccine)
protects immunocompetent adults from herpes zoster and its complications. Success of …

Background The incidence of herpes zoster is up to 9 times higher in immunosuppressed
solid organ transplant recipients than in the general population. We investigated the …

Varicella-zoster virus (VZV) causes herpes zoster after bone marrow transplantation (BMT).
The immunogenicity of heat-inactivated varicella vaccine and effects on VZV pathogenesis …

OBJECTIVE To establish accurate, up-to-date, baseline epidemiological data for herpes
zoster (HZ) before the introduction of the recently licensed HZ vaccine. METHODS Using …

These recommendations represent the first statement by the Advisory Committee on
Immunization Practices (ACIP) on the use of a live attenuated vaccine for the prevention of …

A serum bank maintained for renal transplant recipients allowed for a longitudinal study of
antibody responses before and after herpes zoster. Renal transplant recipients without …

Recombinant herpes zoster (HZ) vaccines may be an alternative to the live-attenuated HZ
vaccine for immunocompromised individuals. This was a phase 1/2, randomized, observer …